Arcellx, Inc.

19
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US03940C1009
USD
114.36
-0.03 (-0.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Arcellx, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-228.00
-105.00
-70.00
-188.00
-64.00
-32.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-57.00
-30.00
225.00
4.00
2.00
1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-210.00
-83.00
207.00
-99.00
-54.00
-28.00
Cash Flow from Investing Activities
86.00
-183.00
-154.00
-117.00
-79.00
0.00
Cash Flow from Financing Activities
98.00
-24.00
279.00
252.00
118.00
41.00
Net Cash Inflow / Outflow
-25.00
-290.00
332.00
35.00
-15.00
12.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Arcellx, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-228.865
-79.992
-149.00
-186.11%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-57.494
-131.016
74.00
56.12%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-210.258
-345.102
135.00
39.07%
Cash Flow from Investing Activities
86.297
-121.438
207.00
171.06%
Cash Flow from Financing Activities
98.534
478.049
-380.00
-79.39%
Net Cash Inflow / Outflow
-25.427
11.509
-36.00
-320.93%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -151.91% vs -140.21% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-210.26
-83.47
-151.91%